BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23718915)

  • 1. Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.
    Seçkin D; Barete S; Euvrard S; Francès C; Kanitakis J; Geusau A; Del Marmol V; Harwood CA; Proby CM; Ali I; Güleç AT; Durukan E; Lebbé C; Alaibac M; Laffitte E; Cooper S; Bouwes Bavinck JN; Murphy GM; Ferrándiz C; Mørk C; Cetkovská P; Kempf W; Hofbauer GF
    Am J Transplant; 2013 Aug; 13(8):2146-53. PubMed ID: 23718915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014.
    Seçkin D
    G Ital Dermatol Venereol; 2014 Aug; 149(4):401-8. PubMed ID: 25068227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of primary cutaneous T-cell lymphoma following solid organ transplantation.
    Shimshak S; Dai C; Comfere N; Sokumbi O
    Int J Dermatol; 2023 Apr; 62(4):494-500. PubMed ID: 35687656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folliculotropic Mycosis Fungoides as a Posttransplant Lymphoproliferative Disorder.
    Spence-Shishido A; Streicher JL; George RP; Parker SR; Lawley LP
    Pediatrics; 2015 Sep; 136(3):e701-5. PubMed ID: 26283779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
    J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 7. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous T-cell lymphoma occurring after organ transplantation.
    Ravat FE; Spittle MF; Russell-Jones R
    J Am Acad Dermatol; 2006 Apr; 54(4):668-75. PubMed ID: 16546591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU
    Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
    Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
    Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
    Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
    J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders.
    Pulitzer M; Geller S; Kumar E; Frosina D; Moskowitz A; Horwitz S; Myskowski P; Kheterpal M; Chan A; Dogan A; Jungbluth A
    Histopathology; 2018 Oct; 73(4):653-662. PubMed ID: 29893430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Cutaneous T-Cell Lymphoma/Mycosis Fungoides Occurring in the Setting of Solid Organ Transplantation: Report of 2 Cases.
    Griffin DB; Hajar T; Simpson E; White KP; Shinohara MM
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e39-e42. PubMed ID: 31924574
    [No Abstract]   [Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
    L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Stephens D; Punnett AS; Barton M; Allen UD
    Am J Transplant; 2019 Oct; 19(10):2764-2774. PubMed ID: 30884098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.
    Muniesa C; Gallardo F; García-Doval I; Estrach MT; Combalia A; Morillo-Andújar M; De la Cruz-Vicente F; Machan S; Moya-Martínez C; Rovira R; Sanchez-Gonzalez B; Acebo E; Amutio E; Peñate Y; Losada-Castillo MDC; García-Muret MP; Iznardo H; Román-Curto C; Cañueto J; Fernández-de-Misa R; Flórez Á; Izu RM; Torres-Navarro I; Zayas A; Pérez-Paredes G; Blanes M; Yanguas JI; Pérez-Ferriols A; Callejas-Charavia M; Ortiz-Romero PL; Pérez-Gil A; Prieto-Torres L; González-Barca E; Servitje O
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):57-64. PubMed ID: 36017748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lymphomas.
    Seçkin D; Hofbauer GF
    Cancer Treat Res; 2009; 146():343-51. PubMed ID: 19415215
    [No Abstract]   [Full Text] [Related]  

  • 18. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
    Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
    Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
    Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
    Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.